Beginning November 1, Medicare will list on-site tests for glycated hemoglobin (HbA1c), which will fund 190,000 tests for Australians with previously diagnosed diabetes.
Monitoring patients...
The SGLT2 inhibitor dapagliflozin is well tolerated regardless of diabetes status according to new analyzes from the DARE-19 study in adults who were hospitalized...